Get the Stockscreener App
0.2175
14.47%
0.0275
After Hours:
.22
0.0025
+1.15%
Geovax Labs Inc stock is traded at $0.2175, with a volume of 3.42M.
It is up +14.47% in the last 24 hours and down -42.32% over the past month.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
See More
Previous Close:
$0.19
Open:
$0.193
24h Volume:
3.42M
Relative Volume:
1.93
Market Cap:
$9.42M
Revenue:
$6.14M
Net Income/Loss:
$-24.81M
P/E Ratio:
-0.0873
EPS:
-2.49
Net Cash Flow:
$-27.40M
1W Performance:
+26.53%
1M Performance:
-42.32%
6M Performance:
-54.70%
1Y Performance:
-91.63%
1-Day Range:
$0.193
$0.2237
1-Week Range:
$0.1706
$0.2237
52-Week Range:
$0.1151
$2.6199
Geovax Labs Inc Stock (GOVX) Company Profile
Name
Geovax Labs Inc
Sector
Industry
Phone
678-384-7220
Address
1900 LAKE PARK DRIVE, SMYRNA
Compare GOVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GOVX
Geovax Labs Inc
|
0.2175 | 8.23M | 6.14M | -24.81M | -27.40M | -2.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Geovax Labs Inc Stock (GOVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-25 | Reiterated | Alliance Global Partners | Buy |
| Apr-15-25 | Reiterated | D. Boral Capital | Buy |
| Nov-11-24 | Initiated | Alliance Global Partners | Buy |
| Jul-16-24 | Initiated | ROTH MKM | Buy |
| Nov-19-20 | Initiated | Maxim Group | Buy |
Geovax Labs Inc Stock (GOVX) Latest News
How GeoVax Labs Inc. stock reacts to bond yieldsStock Split Announcements & Free Risk Assessment and Control - bollywoodhelpline.com
GeoVax Labs to Outline Clinical Progress and Strategic Priorities at Major Healthcare Conferences - citybuzz -
GeoVax Labs, Inc. to Review Progress and Strategic Priorities During Biotech Showcase 2026 and J.P. Morgan Healthcare Conference Week - Yahoo Finance
Is GeoVax Labs Inc. Equity Warrant stock safe for conservative investors2026 world cup usa national team round of 16 young talents build up play odds analysis preview - Улправда
Why GeoVax Labs Inc. stock appeals to dividend seekers2026 world cup usa national team quarterfinals key players counter attacking expert forecast analysis - Улправда
GeoVax shareholders approve warrant exercises - MSN
GOVX News Today | Why did GeoVax Labs stock drop today? - MarketBeat
GeoVax Labs (NASDAQ:GOVX) Shares Up 21.1% – Should You Buy? - Defense World
Is GeoVax Labs Inc a good long term investmentSupport Level Holds & Big Returns Small Capital - earlytimes.in
Sentiment Watch: Why GeoVax Labs Inc stock is favored by top institutionsQuarterly Performance Summary & Real-Time Market Sentiment Reports - moha.gov.vn
GeoVax Labs Inc Equity Warrant Stock Analysis and ForecastDividend Yield Trends & Best Stocks For Explosive Growth - earlytimes.in
Analyst Calls: What dividend safety score for GeoVax Labs Inc Equity Warrant stockQuarterly Trade Report & AI Powered Market Entry Ideas - moha.gov.vn
GeoVax Labs announces public equity offering for liquidity - MSN
Is Now the Best Entry Point for Orient Cement Limited StockCovered Call Writing & Fast Profit Strategies - earlytimes.in
GeoVax Labs Announces Public Equity Offering for Liquidity - The Globe and Mail
GeoVax Labs Signs Multiple Material Agreements - TradingView — Track All Markets
Market Wrap: Can GeoVax Labs Inc stock deliver sustainable ROE2025 Price Momentum & Expert Approved Momentum Ideas - moha.gov.vn
Why GeoVax Labs Inc. stock is recommended by analystsQuarterly Earnings Report & Proven Capital Preservation Methods - Улправда
Is GeoVax Labs Inc. stock a bargain at current levelsJuly 2025 Closing Moves & Safe Investment Capital Preservation Plans - Улправда
Can GeoVax Labs Inc. stock sustain institutional interestGold Moves & Fast Moving Trade Plans - Улправда
Analyst Downgrade: How GeoVax Labs Inc. Equity Warrant stock reacts to inflationary pressuresJuly 2025 Decliners & Accurate Entry and Exit Point Alerts - Улправда
Why GeoVax Labs Inc. stock is a must watch in 20252025 Market Overview & Stock Portfolio Risk Management - Улправда
Geovax Labs Stock Slides 61% With A 9-Day Losing Spree - Trefis
Will GeoVax Labs Inc. stock outperform Nasdaq indexPrice Action & Free Low Drawdown Momentum Trade Ideas - Улправда
GeoVax Announces $3.2 Million Public Offering to Fund Clinical-Stage Vaccine and Cancer Therapy Development - citybuzz -
Why GeoVax Labs Inc. stock attracts global investors2025 Market WrapUp & Weekly Return Optimization Alerts - Улправда
Dow Gains Over 200 Points; Conagra Shares Fall After Q2 Results - Sahm
What dividend safety score for GeoVax Labs Inc. Equity Warrant stock2025 Trade Ideas & Risk Managed Trade Strategies - DonanımHaber
GeoVax to Raise Approximately $3.2 Million of Gross Proceeds in Public Offering - Yahoo Finance
How GeoVax Labs Inc. Equity Warrant stock responds to policy changesJuly 2025 Closing Moves & Daily Oversold Stock Bounce Ideas - DonanımHaber
How GeoVax Labs Inc. stock performs after earnings2025 Support & Resistance & Verified Technical Trade Signals - DonanımHaber
Why GeoVax Labs Inc. stock is popular among millennialsJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - Улправда
Is GeoVax Labs Inc. Equity Warrant stock attractive for growth ETFs2025 Earnings Surprises & Fast Gaining Stock Strategy Reports - DonanımHaber
Can GeoVax Labs Inc. Equity Warrant stock beat market expectations this quarterMarket Sentiment Summary & Weekly Return Optimization Plans - DonanımHaber
Why GeoVax Labs Inc. stock remains a top recommendationDip Buying & AI Powered Buy and Sell Recommendations - DonanımHaber
Why GeoVax Labs Inc. Equity Warrant stock could be next big winner2025 Big Picture & Daily Entry Point Trade Alerts - Улправда
How currency fluctuations impact GeoVax Labs Inc. stockCPI Data & Weekly Setup with ROI Potential - Улправда
Market Rankings: Can GeoVax Labs Inc. stock sustain institutional interestJuly 2025 Pullbacks & Real-Time Volume Spike Alerts - Улправда
Market Review: Why GeoVax Labs Inc. stock is a must watch in 20252025 Performance Recap & Capital Efficiency Focused Ideas - Улправда
GeoVax Receives EMA Scientific Advice for Phase 3 Trial of Mpox and Smallpox Vaccine Candidate - citybuzz -
GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine - Yahoo Finance
GeoVax Receives Formal EMA Scientific Advice Supporting Pivotal Phase 3 Immunobridging Trial for GEO-MVA - Yahoo Finance
Sentiment Watch: Why GeoVax Labs Inc. stock appeals to dividend seekersJuly 2025 Decliners & AI Forecast Swing Trade Picks - ulpravda.ru
GeoVax Advances Domestic Mpox Vaccine Production with Manufacturing Milestone - citybuzz -
GeoVax Announces Completion of GEO-MVA Fill-Finish, Supporting Phase 3 Immunobridging Clinical Trial Start-Up in Early 2026 - Yahoo Finance
Geovax Labs Inc (GOVX) stock: A year of ups and downs - uspostnews.com
GeoVax Receives U.S. Patent Office Notice of Allowance for Broad-Spectrum COVID-19 Vaccine Design - Yahoo Finance
GeoVax’s Next-Generation COVID-19 Vaccine Shows Superior T-Cell Response in CLL Patients, Trial Advances Exclusively – citybuzz - citybuzz
GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients - Yahoo Finance
What drives GeoVax Labs Inc stock priceMarket Breadth Indicators & Buy Sell Timing Alerts - earlytimes.in
Published on: 2025-12-15 02:46:59 - earlytimes.in
Geovax Labs Inc Stock (GOVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):